Elizabeth Yeu Lin Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity

Elizabeth Yeu Lin is Chief Medical Officer of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 21,941 shares of TARS, which is worth approximately $1.58 Million. The most recent transaction as insider was on Dec 16, 2025, when has been sold 2,078 shares (Common Stock) at a price of $79.5 per share, resulting in proceeds of $165,201. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.9K

185.17% 3M change

310.11% 12M change

Total Value Held $1.58 Million

Elizabeth Yeu Lin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2025	SELL Open market or private sale	$165,201 $79.5 p/Share	2,078 Reduced 8.65%	21,941 Common Stock
Dec 15 2025	BUY Exercise of conversion of derivative security	-	6,819 Added 22.11%	24,019 Common Stock
Jun 16 2025	SELL Open market or private sale	$41,326 $41.08 p/Share	1,006 Reduced 11.56%	7,694 Common Stock
Jun 13 2025	BUY Exercise of conversion of derivative security	-	3,350 Added 27.8%	8,700 Common Stock
Jun 24 2024	BUY Exercise of conversion of derivative security	-	3,350 Added 38.51%	5,350 Common Stock
Jun 16 2023	BUY Exercise of conversion of derivative security	-	2,000 Added 50.0%	2,000 Common Stock

Also insider at

STAA

STAAR SURGICAL CO Healthcare

EYL